Enfermedades retinianas y nuevas terapias
Universidade Do Porto
Oporto, PortugalPublicaciones en colaboración con investigadores/as de Universidade Do Porto (2)
2015
-
Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to pathologic myopia six years outcome
Retina, Vol. 35, Núm. 12, pp. 2450-2456
-
Role of Systemic Anti-Tumor Necrosis Factor Alpha Treatment in the Reduction of Proliferative Vitreoretinopathy
Journal of Clinical & Experimental Ophthalmology, Vol. 06, Núm. 04